Antimicrobial Stewardship

Latest News

When Should We De-Escalate Empiric Antimicrobials?
When Should We De-Escalate Empiric Antimicrobials?

May 6th 2025

De-escalating empiric antimicrobial therapy is a strategy to combat antimicrobial resistance. Antimicrobial stewardship programs can play a major role in preserving antibiotic effectiveness and preventing unnecessary antibiotic use.

Addressing Gram-Negative Infections With Further Insights From Cefiderocol's PROVE Study
Addressing Gram-Negative Infections With Further Insights From Cefiderocol's PROVE Study

May 5th 2025

Prompts in Computerized Order Entry Improve Antimicrobial Treatment for Skin, Soft Tissue Infections
Prompts in Computerized Order Entry Improve Antimicrobial Treatment for Skin, Soft Tissue Infections

May 4th 2025

Dose Optimization as a Strategy to Improve Clinical Outcomes and Suppress Antimicrobial Resistance
Dose Optimization as a Strategy to Improve Clinical Outcomes and Suppress Antimicrobial Resistance

May 2nd 2025

Pneumonia Antibiotic Cures Lyme Disease at Doses 100 Times Lower Than Standard Treatment
Pneumonia Antibiotic Cures Lyme Disease at Doses 100 Times Lower Than Standard Treatment

April 29th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.